Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
9 studies found for:    17194875 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Absolute Quantification of Coronary Flow Reserve by Stress Perfusion MRI
Condition: Myocardial Ischemia
Interventions: Drug: Regadenoson;   Drug: gadofoveset trisodium
2 Active, not recruiting HEART Pathway Implementation
Conditions: Chest Pain;   Acute Coronary Syndrome;   Chest Pain Atypical Syndrome;   Chest Pain Rule Out Myocardial Infarction
Intervention:
3 Active, not recruiting Efficacy Evaluation of the HEART Pathway in Emergency Department Patients With Acute Chest Pain
Conditions: Acute Coronary Syndrome;   Chest Pain
Intervention: Other: HEART Pathway
4 Completed
Has Results
Randomized Investigation of Chest Pain Diagnostic Strategies
Conditions: Acute Coronary Syndrome;   Chest Pain
Intervention: Other: Clinical decision unit care, coupled with cardiac MRI
5 Unknown  "Cryptogenic Stroke and Atrial Fibrillation Detection Through Implantable Loop Recorder (ILR)"
Conditions: Atrial Fibrillation;   Stroke
Intervention:
6 Active, not recruiting Ischemic Conditioning in STEMI Patients
Condition: Cardiac Arrest
Intervention: Procedure: Remote post-ischemic conditioning
7 Completed Efficacy Evaluation of Observation Unit Cardiac Magnetic Resonance Imaging (MRI) in Patients With Intermediate Risk Acute Chest Pain
Conditions: Acute Coronary Syndrome;   Chest Pain
Interventions: Other: OU - Cardiac MRI;   Other: OU - Conventional Care Testing
8 Recruiting Lp(a) and Aortic Valve Calcification
Condition: Heterozygous Familial Hypercholesterolemia
Intervention:
9 Completed A Study Of Nutraceutical Drinks For Cholesterol (Evaluating Effectiveness and Tolerability)
Condition: Hyperlipidemia
Interventions: Dietary Supplement: Placebo;   Dietary Supplement: Second Formulation;   Dietary Supplement: Third Formulation

Study has passed its completion date and status has not been verified in more than two years.